B.P. Marsh & Partners PLC (LON:BPM - Get Free Report) insider Francesca Chappell acquired 764 shares of the stock in a transaction dated Tuesday, June 10th. The shares were bought at an average price of GBX 652 ($8.84) per share, for a total transaction of £4,981.28 ($6,752.45).
Francesca Chappell also recently made the following trade(s):
- On Monday, April 7th, Francesca Chappell acquired 610 shares of B.P. Marsh & Partners stock. The shares were bought at an average price of GBX 649 ($8.80) per share, for a total transaction of £3,958.90 ($5,366.54).
B.P. Marsh & Partners Trading Up 4.7%
Shares of B.P. Marsh & Partners stock traded up GBX 30 ($0.41) on Wednesday, hitting GBX 670 ($9.08). 208,022 shares of the company traded hands, compared to its average volume of 90,927. The firm's 50-day simple moving average is GBX 669.27 and its 200 day simple moving average is GBX 689.77. The company has a market cap of £248.50 million, a P/E ratio of 4.60 and a beta of 0.71. B.P. Marsh & Partners PLC has a 12-month low of GBX 490.11 ($6.64) and a 12-month high of GBX 760 ($10.30).
B.P. Marsh & Partners (LON:BPM - Get Free Report) last posted its quarterly earnings data on Tuesday, June 10th. The insurance provider reported GBX 269.50 ($3.65) earnings per share for the quarter. B.P. Marsh & Partners had a net margin of 577.55% and a return on equity of 22.24%. Analysts predict that B.P. Marsh & Partners PLC will post 61.4500021 earnings per share for the current year.
About B.P. Marsh & Partners
(
Get Free Report)
B.P. Marsh & Partners PLC is a specialist venture capital / private equity investor in early stage financial services intermediary businesses, including insurance intermediaries, financial advisors, wealth and fund managers and specialist advisory and consultancy firms. It considers investment opportunities based in the United Kingdom, Europe, North America and Internationally.
The Group invests amounts of up to £5m in the first round.
Further Reading
Before you consider B.P. Marsh & Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and B.P. Marsh & Partners wasn't on the list.
While B.P. Marsh & Partners currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
